Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Licenses OncoMethylome MGMT Methylation IP

NEW YORK (GenomeWeb News) – LabCorp has obtained an exclusive license granting it access to MGMT methylation-related IP technology developed by the molecular diagnostics company OncoMethylome Sciences, the companies announced today.

The move will allow LabCorp to do commercial MGMT methylation laboratory testing in the US and Canada, with limited exceptions. OncoMethylome also named LabCorp’s Esoterix Clinical Trials Services Division as one of its preferred subcontractors for clinical trial MGMT methylation testing services.

Under the agreement, LabCorp will provide an upfront fee, milestone payments, and royalties to OncoMethylome. Other terms of the agreement were not disclosed.

Methylation is a chemical modification that influences gene expression. In certain situations, gene silencing by aberrant methylation is associated with cancer development and progression. OncoMethylome’s products, which are based on technology developed at Johns Hopkins University, are sensitive tools used to detect such methylation.

Specifically, LabCorp intends to use OncoMethylome’s methylation-specific PCR technology to test the methylation status of MGMT, a gene coding for a DNA repair protein. MGMT is often methylated in cancerous cells and its methylation may even predict a patient’s response to some cancer treatments.

For instance, in those with malignant brain tumors, MGMT methylation seems to predict patient response to alkylating agent-based chemotherapy, said OncoMethylome. Consequently, the predictive properties of MGMT methylation are also being tested in several clinical trials of brain and other cancers.

“Laboratory tests for gene methylation are an important and differentiating addition to our menu of oncology services and allow us to offer a more complete package of services to oncologist and their patients,” LabCorp Executive Vice President, Medical Director, and CSO Myla Lai-Goldman said in a statement.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.